Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2

doi:10.1038/s41422-021-00570-1

	Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2
	Xie, Yuanchao 1; Yin, Wanchao 1; Zhang, Yumin 2; Shang, Weijuan 2; Wang, Zhen 1; Luan, Xiaodong 3,4,5; Tian, Guanghui 6; Aisa, Haji A.7,8; Xu, Yechun 1,7; Xiao, Gengfu 2,7
刊名	CELL RESEARCH
	2021-09-28
页码	3
ISSN号	1001-0602
DOI	10.1038/s41422-021-00570-1
通讯作者	Zhang, Leike(zhangleike@wh.iov.cn) ; Xu, H. Eric(eric.xu@simm.ac.cn) ; Shen, Jingshan(shenjingshan@simm.ac.cn)
资助项目	National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China[2018ZX09711002] ; National Key R&D Program of China[2018YFA0507002] ; Shanghai Municipal Science and Technology Major Project[2019SHZDZX02] ; Strategic Priority Research Program of Chinese Academy of Sciences[XDB37030103] ; Youth Innovation Promotion Association of Chinese Academy of Sciences[2018367] ; Youth Innovation Promotion Association of Chinese Academy of Sciences[2021278] ; Shanghai Science and Technology Committee[21S11903100] ; National Natural Science Foundation of China[31970165] ; 2020 ANSO Collaborative Research Project[ANSO-CR-SP-2020-03]
WOS研究方向	Cell Biology
语种	英语
出版者	SPRINGERNATURE
WOS记录号	WOS:000701643700001
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/297570]
专题	中国科学院上海药物研究所
通讯作者	Zhang, Leike; Xu, H. Eric; Shen, Jingshan
作者单位	1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China 2.Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China 3.Tsinghua Univ, Sch Med, Beijing, Peoples R China 4.Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing, Peoples R China 5.Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China 6.Vigonvita Life Sci Co Ltd, Suzhou, Jiangsu, Peoples R China 7.Univ Chinese Acad Sci, Beijing, Peoples R China 8.Chinese Acad Sci, Xinjiang Tech Inst Phys & Chem, Key Lab Plant Resources & Chem Arid Reg, Urumqi, Xinjiang, Peoples R China 9.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
推荐引用方式 GB/T 7714	Xie, Yuanchao,Yin, Wanchao,Zhang, Yumin,et al. Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2[J]. CELL RESEARCH,2021:3.
APA	Xie, Yuanchao.,Yin, Wanchao.,Zhang, Yumin.,Shang, Weijuan.,Wang, Zhen.,...&Shen, Jingshan.(2021).Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2.CELL RESEARCH,3.
MLA	Xie, Yuanchao,et al."Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2".CELL RESEARCH (2021):3.